Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
69.97
-0.30 (-0.43%)
At close: Oct 10, 2025, 4:00 PM EDT
70.42
+0.45 (0.64%)
After-hours: Oct 10, 2025, 7:59 PM EDT

Ionis Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Net Income
-268.22-453.9-366.29-269.72-28.6-479.74
Upgrade
Depreciation & Amortization
21.6121.9922.522.1119.5617.16
Upgrade
Stock-Based Compensation
127.54130.2105.81100.26120.68230.12
Upgrade
Other Adjustments
20.610.157.73-134.5932.98341.91
Upgrade
Change in Receivables
-25.325.59-72.0636.3614.31-13.17
Upgrade
Changes in Inventories
-17.24-5.07-2.475.33-2.84-1.26
Upgrade
Changes in Accounts Payable
12.7515.998.121.09-6-2.76
Upgrade
Changes in Accrued Expenses
11.29-41.1113.0457.06-35.360.8
Upgrade
Changes in Income Taxes Payable
-0.2-2.12-4.16.21-0.28-31.19
Upgrade
Changes in Unearned Revenue
-81.76-156.8213.97-71.25-82.83-75.91
Upgrade
Changes in Other Operating Activities
-39.01-25.86-33.76-27.24-0.88-10.06
Upgrade
Operating Cash Flow
-230.57-500.95-307.51-274.3730.835.89
Upgrade
Operating Cash Flow Growth
-----14.19%-89.61%
Upgrade
Capital Expenditures
-59.44-45.28-23.81-15.72-11.96-35.12
Upgrade
Sale of Property, Plant & Equipment
--0.02254.08--
Upgrade
Purchases of Intangible Assets
7.59-5.06-4.21-4.38-5.95-5.93
Upgrade
Purchases of Investments
-1,852-1,853-1,771-1,486-1,131-1,570
Upgrade
Proceeds from Sale of Investments
1,6811,7691,585989.151,3441,886
Upgrade
Investing Cash Flow
-222.19-134.03-214.13-262.64194.91274.48
Upgrade
Long-Term Debt Issued
--575-632.5-
Upgrade
Long-Term Debt Repaid
-0-44.5-487.94-10.95-318.93-
Upgrade
Net Long-Term Debt Issued (Repaid)
-0-44.587.06-10.95313.57-
Upgrade
Issuance of Common Stock
10.93522.7349.446.3711.5752.04
Upgrade
Repurchase of Common Stock
--0.17-0.16-50.69-16.73-103.96
Upgrade
Net Common Stock Issued (Repurchased)
10.93522.5649.28-44.31-5.16-51.92
Upgrade
Other Financing Activities
--507.74-0.03-62.48-544.69
Upgrade
Financing Cash Flow
455.38478.06644.08-55.3245.93-596.61
Upgrade
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.69-0.270.35-0.42-0.110.62
Upgrade
Net Cash Flow
3.31-157.19122.79-592.72471.53-285.62
Upgrade
Beginning Cash & Cash Equivalents
293.99399.27276.47869.19397.66683.29
Upgrade
Ending Cash & Cash Equivalents
297.3242.08399.27276.47869.19397.66
Upgrade
Free Cash Flow
-290-546.23-331.32-290.0918.840.77
Upgrade
Free Cash Flow Growth
----2340.93%-99.76%
Upgrade
FCF Margin
-30.72%-77.46%-42.06%-49.39%2.33%0.11%
Upgrade
Free Cash Flow Per Share
-1.79-3.65-2.31-2.050.130.01
Upgrade
Levered Free Cash Flow
-433.67-749.01-221.1-279.6163.35-522.61
Upgrade
Unlevered Free Cash Flow
-424.54-719.72-326-413.93-151.28191.05
Upgrade
Updated Jul 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q